Moreover, no significant findings were found on complete blood count (CBC), chemistry profile, serum tumor marker tests (carcinoembryonic antigen [CEA], prostate-specific antigen [PSA], and cancer antigen [CA 19–9]), and urine analysis. This evidence concerns the gene KLK3 and neoplasm.